Tejido adiposo epicardico y su asociacion con niveles plasmaticosde adrenomedulina en pacientes con sindrome metabolico

Translated title of the contribution: Epicardial adipose tissue and its association to plasma adrenomedullin levels inpatients with metabolic syndrome

Christopher Torres, Marcos M. Lima-Martínez, Francisco J. Rosa, Ernesto Guerra, Mariela Paoli, Gianluca Iacobellis, Marianela Rodney, Eduardo Romero-Vecchione, Maria Luisa Saadtjian, Moisés Zagala, Henry Rodney

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

To assess the association between epicardial adipose tissue thickness (EAT) and plasma adrenomedullin plasma levels in patients with metabolic syndrome (MS). Methods: Twenty-one patients (12 females and 9 males) with MS according to the International Diabetes Federation guidelines, aged 22-58 years, were enrolled into the study and compared to 19 age-matched control subjects without MS. Plasma glucose, lipid, and adrenomedullin levels were assessed. EAT, left ventricular mass, and carotid intima-media thickness were evaluated by transthoracic two-dimensional echocardiography. Results: No statistically significant differences were found between the groups in age, sex, and height. Body weight, abdominal circumference (AC), body mass index (BMI), systolic blood pressure (SBP), and diastolic blood pressure (DBP) were significantly higher (p=0.0001) in MS patients; this group also showed significantly higher glucose (p=0.001), total cholesterol (p=0.01), LDL-C (p=0.03), VLDL-C (p=0.005), triglyceride (p=0.002), Tg/HDL ratio (p=0.0001), and plasma adrenomedullin (3.49±1.21 vs 1.69±0.92 ng/mL; p=0.0001) levels and lower HDL-C (p=0.02) levels as compared to the control group. EAT was significantly thicker in MS patients compared to the control group (8.45±3.14 vs 5.43±0.96; p=0.0001), showed a positive correlation to BMI (r=0.347; p=0.02), AC (r=0.350; p=0.02), DBP (r=0.346; p=0.02), and adrenomedullin levels (r=0.741; p=0.0001). In multiple linear regression analysis, adrenomedullin was the only parameter associated to EAT (R2=0.550; p=0.0001). Conclusion: In this small patient group, a statistically significant association was found between EAT and plasma adrenomedullin levels, which may be considered as a potential biomarker of MS.

Original languageSpanish
Pages (from-to)401-408
Number of pages8
JournalEndocrinologia y Nutricion
Volume58
Issue number8
DOIs
StatePublished - Oct 1 2011

Fingerprint

Adrenomedullin
Adipose Tissue
Inpatients
Blood Pressure
Body Mass Index
Glucose
Carotid Intima-Media Thickness
Control Groups
Echocardiography
Linear Models
Triglycerides
Age Groups
Biomarkers
Cholesterol
Body Weight
Regression Analysis
Guidelines
Lipids

Keywords

  • Adrenomedullin
  • Atherosclerosis
  • Epicardial adipose tissue
  • Metabolic syndrome

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Tejido adiposo epicardico y su asociacion con niveles plasmaticosde adrenomedulina en pacientes con sindrome metabolico. / Torres, Christopher; Lima-Martínez, Marcos M.; Rosa, Francisco J.; Guerra, Ernesto; Paoli, Mariela; Iacobellis, Gianluca; Rodney, Marianela; Romero-Vecchione, Eduardo; Luisa Saadtjian, Maria; Zagala, Moisés; Rodney, Henry.

In: Endocrinologia y Nutricion, Vol. 58, No. 8, 01.10.2011, p. 401-408.

Research output: Contribution to journalArticle

Torres, C, Lima-Martínez, MM, Rosa, FJ, Guerra, E, Paoli, M, Iacobellis, G, Rodney, M, Romero-Vecchione, E, Luisa Saadtjian, M, Zagala, M & Rodney, H 2011, 'Tejido adiposo epicardico y su asociacion con niveles plasmaticosde adrenomedulina en pacientes con sindrome metabolico', Endocrinologia y Nutricion, vol. 58, no. 8, pp. 401-408. https://doi.org/10.1016/j.endonu.2011.06.002
Torres, Christopher ; Lima-Martínez, Marcos M. ; Rosa, Francisco J. ; Guerra, Ernesto ; Paoli, Mariela ; Iacobellis, Gianluca ; Rodney, Marianela ; Romero-Vecchione, Eduardo ; Luisa Saadtjian, Maria ; Zagala, Moisés ; Rodney, Henry. / Tejido adiposo epicardico y su asociacion con niveles plasmaticosde adrenomedulina en pacientes con sindrome metabolico. In: Endocrinologia y Nutricion. 2011 ; Vol. 58, No. 8. pp. 401-408.
@article{0c605fde33aa4b3793bbf18c9026abc6,
title = "Tejido adiposo epicardico y su asociacion con niveles plasmaticosde adrenomedulina en pacientes con sindrome metabolico",
abstract = "To assess the association between epicardial adipose tissue thickness (EAT) and plasma adrenomedullin plasma levels in patients with metabolic syndrome (MS). Methods: Twenty-one patients (12 females and 9 males) with MS according to the International Diabetes Federation guidelines, aged 22-58 years, were enrolled into the study and compared to 19 age-matched control subjects without MS. Plasma glucose, lipid, and adrenomedullin levels were assessed. EAT, left ventricular mass, and carotid intima-media thickness were evaluated by transthoracic two-dimensional echocardiography. Results: No statistically significant differences were found between the groups in age, sex, and height. Body weight, abdominal circumference (AC), body mass index (BMI), systolic blood pressure (SBP), and diastolic blood pressure (DBP) were significantly higher (p=0.0001) in MS patients; this group also showed significantly higher glucose (p=0.001), total cholesterol (p=0.01), LDL-C (p=0.03), VLDL-C (p=0.005), triglyceride (p=0.002), Tg/HDL ratio (p=0.0001), and plasma adrenomedullin (3.49±1.21 vs 1.69±0.92 ng/mL; p=0.0001) levels and lower HDL-C (p=0.02) levels as compared to the control group. EAT was significantly thicker in MS patients compared to the control group (8.45±3.14 vs 5.43±0.96; p=0.0001), showed a positive correlation to BMI (r=0.347; p=0.02), AC (r=0.350; p=0.02), DBP (r=0.346; p=0.02), and adrenomedullin levels (r=0.741; p=0.0001). In multiple linear regression analysis, adrenomedullin was the only parameter associated to EAT (R2=0.550; p=0.0001). Conclusion: In this small patient group, a statistically significant association was found between EAT and plasma adrenomedullin levels, which may be considered as a potential biomarker of MS.",
keywords = "Adrenomedullin, Atherosclerosis, Epicardial adipose tissue, Metabolic syndrome",
author = "Christopher Torres and Lima-Mart{\'i}nez, {Marcos M.} and Rosa, {Francisco J.} and Ernesto Guerra and Mariela Paoli and Gianluca Iacobellis and Marianela Rodney and Eduardo Romero-Vecchione and {Luisa Saadtjian}, Maria and Mois{\'e}s Zagala and Henry Rodney",
year = "2011",
month = "10",
day = "1",
doi = "10.1016/j.endonu.2011.06.002",
language = "Spanish",
volume = "58",
pages = "401--408",
journal = "Endocrinologia, Diabetes y Nutricion",
issn = "2530-0164",
publisher = "Elsevier BV",
number = "8",

}

TY - JOUR

T1 - Tejido adiposo epicardico y su asociacion con niveles plasmaticosde adrenomedulina en pacientes con sindrome metabolico

AU - Torres, Christopher

AU - Lima-Martínez, Marcos M.

AU - Rosa, Francisco J.

AU - Guerra, Ernesto

AU - Paoli, Mariela

AU - Iacobellis, Gianluca

AU - Rodney, Marianela

AU - Romero-Vecchione, Eduardo

AU - Luisa Saadtjian, Maria

AU - Zagala, Moisés

AU - Rodney, Henry

PY - 2011/10/1

Y1 - 2011/10/1

N2 - To assess the association between epicardial adipose tissue thickness (EAT) and plasma adrenomedullin plasma levels in patients with metabolic syndrome (MS). Methods: Twenty-one patients (12 females and 9 males) with MS according to the International Diabetes Federation guidelines, aged 22-58 years, were enrolled into the study and compared to 19 age-matched control subjects without MS. Plasma glucose, lipid, and adrenomedullin levels were assessed. EAT, left ventricular mass, and carotid intima-media thickness were evaluated by transthoracic two-dimensional echocardiography. Results: No statistically significant differences were found between the groups in age, sex, and height. Body weight, abdominal circumference (AC), body mass index (BMI), systolic blood pressure (SBP), and diastolic blood pressure (DBP) were significantly higher (p=0.0001) in MS patients; this group also showed significantly higher glucose (p=0.001), total cholesterol (p=0.01), LDL-C (p=0.03), VLDL-C (p=0.005), triglyceride (p=0.002), Tg/HDL ratio (p=0.0001), and plasma adrenomedullin (3.49±1.21 vs 1.69±0.92 ng/mL; p=0.0001) levels and lower HDL-C (p=0.02) levels as compared to the control group. EAT was significantly thicker in MS patients compared to the control group (8.45±3.14 vs 5.43±0.96; p=0.0001), showed a positive correlation to BMI (r=0.347; p=0.02), AC (r=0.350; p=0.02), DBP (r=0.346; p=0.02), and adrenomedullin levels (r=0.741; p=0.0001). In multiple linear regression analysis, adrenomedullin was the only parameter associated to EAT (R2=0.550; p=0.0001). Conclusion: In this small patient group, a statistically significant association was found between EAT and plasma adrenomedullin levels, which may be considered as a potential biomarker of MS.

AB - To assess the association between epicardial adipose tissue thickness (EAT) and plasma adrenomedullin plasma levels in patients with metabolic syndrome (MS). Methods: Twenty-one patients (12 females and 9 males) with MS according to the International Diabetes Federation guidelines, aged 22-58 years, were enrolled into the study and compared to 19 age-matched control subjects without MS. Plasma glucose, lipid, and adrenomedullin levels were assessed. EAT, left ventricular mass, and carotid intima-media thickness were evaluated by transthoracic two-dimensional echocardiography. Results: No statistically significant differences were found between the groups in age, sex, and height. Body weight, abdominal circumference (AC), body mass index (BMI), systolic blood pressure (SBP), and diastolic blood pressure (DBP) were significantly higher (p=0.0001) in MS patients; this group also showed significantly higher glucose (p=0.001), total cholesterol (p=0.01), LDL-C (p=0.03), VLDL-C (p=0.005), triglyceride (p=0.002), Tg/HDL ratio (p=0.0001), and plasma adrenomedullin (3.49±1.21 vs 1.69±0.92 ng/mL; p=0.0001) levels and lower HDL-C (p=0.02) levels as compared to the control group. EAT was significantly thicker in MS patients compared to the control group (8.45±3.14 vs 5.43±0.96; p=0.0001), showed a positive correlation to BMI (r=0.347; p=0.02), AC (r=0.350; p=0.02), DBP (r=0.346; p=0.02), and adrenomedullin levels (r=0.741; p=0.0001). In multiple linear regression analysis, adrenomedullin was the only parameter associated to EAT (R2=0.550; p=0.0001). Conclusion: In this small patient group, a statistically significant association was found between EAT and plasma adrenomedullin levels, which may be considered as a potential biomarker of MS.

KW - Adrenomedullin

KW - Atherosclerosis

KW - Epicardial adipose tissue

KW - Metabolic syndrome

UR - http://www.scopus.com/inward/record.url?scp=80053601509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053601509&partnerID=8YFLogxK

U2 - 10.1016/j.endonu.2011.06.002

DO - 10.1016/j.endonu.2011.06.002

M3 - Article

C2 - 21824828

AN - SCOPUS:80053601509

VL - 58

SP - 401

EP - 408

JO - Endocrinologia, Diabetes y Nutricion

JF - Endocrinologia, Diabetes y Nutricion

SN - 2530-0164

IS - 8

ER -